November 29, 2023

MultiplexDX, in cooperation with JIC, organized the first workshop from its Soft Skills program series

MultiplexDX, in cooperation with JIC (Jihomoravske Inovacni Centrum), kicked off the Soft Skills program by organizing the first workshop on the topic: IPR & Entrepreneurship in Biotech. The Soft Skills program is part of the ADDIT-CE project. The Czech-Slovak consortium and center of excellence aims to develop, validate, and implement modern and innovative diagnostics for Alzheimer's disease.

Workshop participants learned more about - When it is crucial to address intellectual property protection in biotechnology? How to protect innovative processes and inventions, which are often the most valuable assets in the scientific world? What is the path from an idea to establishing a company and owning a business in this sphere?

The workshop took place on November 28th at 10:00 AM online.

About MultiplexDX

MultiplexDX is one of the most innovative biotech corporations, created to bring its revolutionary technologies to the market of personalized molecular diagnostics. The company has representation in both U.S. and European markets. The collaborators of MultiplexDX are from the world’s most prestigious scientific organizations including the National Cancer Institute, Rockefeller University, Albert Einstein University, Vanderbilt University, Cornell University, Queens University (Canada), Hebrew University of Jerusalem (Israel), and the Max Delbrück Center for Molecular Medicine (Germany).

MultiplexDX IP-based and innovative platform merges histopathology methods, biomarker quantification, visualization and gene expression with a single-cell resolution by combining MDX proprietary visual and sequencing technologies into one diagnostic test. This cross-validation approach eliminates diagnostic errors and creates 100% precise cancer profiling for each patient which allows clinicians to suggest specific, personalized cancer treatment.

Find out more about MultiplexDX on Corporate website, Facebook, LinkedIn, Twitter

Other latest

MultiplexDX News